Paper28477166
The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.
Tian F and 4 others. Eur Radiol, 2017. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review. Papers, record 28477166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28477166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Fluorodeoxyglucose F18 | Major topic |
| Positron Emission Tomography Computed Tomography | Major topic |
| Radiopharmaceuticals | Major topic |
| Breast | |
| Chemotherapy, Adjuvant | |
| Female | |
| Humans | |
| Lymph Nodes | |
| Neoadjuvant Therapy | |
| Odds Ratio | |
| Sensitivity and Specificity |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81571637 | National Natural Science Foundation of China | PubMed | ||
| 81271532 | National Natural Science Foundation of China | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24841218 | Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer. | Eur J Cancer | 2014 | https://conductscience.org/library/papers/24841218 | PubMed |
| 2 | 24647576 | HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24647576 | PubMed |
| 3 | 26953659 | Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer. | Clin Nucl Med | 2016 | https://conductscience.org/library/papers/26953659 | PubMed |
| 4 | 23504954 | Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy. | Cancer | 2013 | https://conductscience.org/library/papers/23504954 | PubMed |
| 5 | 22499859 | Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. | Ann Oncol | 2012 | https://conductscience.org/library/papers/22499859 | PubMed |
| 6 | 11870173 | Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11870173 | PubMed |
| 7 | 26834099 | ¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer. | J Nucl Med | 2016 | https://conductscience.org/library/papers/26834099 | PubMed |
| 8 | 25476537 | TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer. | J Nucl Med | 2015 | https://conductscience.org/library/papers/25476537 | PubMed |
| 9 | 25915099 | Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype. | Radiology | 2015 | https://conductscience.org/library/papers/25915099 | PubMed |
| 10 | 10673991 | Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. | Eur J Cancer | 1999 | https://conductscience.org/library/papers/10673991 | PubMed |
| 11 | 26336821 | 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/26336821 | PubMed |
| 12 | 22438441 | Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment. | Radiology | 2012 | https://conductscience.org/library/papers/22438441 | PubMed |
| 13 | 25072926 | Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. | Clin Nucl Med | 2014 | https://conductscience.org/library/papers/25072926 | PubMed |
| 14 | 26205180 | Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. | Mod Pathol | 2015 | https://conductscience.org/library/papers/26205180 | PubMed |
| 15 | 3287615 | Measuring the accuracy of diagnostic systems. | Science | 1988 | https://conductscience.org/library/papers/3287615 | PubMed |
| 16 | 21830087 | 18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response. | Int J Clin Oncol | 2012 | https://conductscience.org/library/papers/21830087 | PubMed |
| 17 | 8622014 | Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8622014 | PubMed |
| 18 | 22734080 | 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. | Acta Radiol | 2012 | https://conductscience.org/library/papers/22734080 | PubMed |
| 19 | 19877158 | The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging. | J Surg Oncol | 2010 | https://conductscience.org/library/papers/19877158 | PubMed |
| 20 | 8229124 | Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8229124 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793693 | Association of PET/CT-Derived Metabolic Parameters with Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: An Analysis Across Molecular Subtypes. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42793693 | PubMed |
| 42230653 | Diagnostic Performance of 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT in Evaluating Neoadjuvant Therapy Pathological Response in Breast Cancer. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42230653 | PubMed |
| 42165827 | FDG PET Hybrid Imaging. | Recent Results Cancer Res | 2026 | https://conductscience.org/library/papers/42165827 | PubMed |
| 42089524 | The Future of Quantitative Breast Imaging: Integrated to Integral Imaging Biomarkers for Precision Cancer Care, From the AJR Special Series on Quantitative Imaging. | AJR Am J Roentgenol | 2026 | https://conductscience.org/library/papers/42089524 | PubMed |
| 42035386 | Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art. | EJNMMI Radiopharm Chem | 2026 | https://conductscience.org/library/papers/42035386 | PubMed |
| 41944968 | A narrative review: key evidence from meta-analyses in nuclear medicine. | Ann Nucl Med | 2026 | https://conductscience.org/library/papers/41944968 | PubMed |
| 41922613 | [68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report. | EJNMMI Res | 2026 | https://conductscience.org/library/papers/41922613 | PubMed |
| 41901569 | Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41901569 | PubMed |
| 39692805 | Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer? | Ir J Med Sci | 2025 | https://conductscience.org/library/papers/39692805 | PubMed |
| 39338206 | Peritumoral Adipose Tissue Features Derived from [18F]fluoro-2-deoxy-2-d-glucose Positron Emission Tomography/Computed Tomography as Predictors for Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. | J Pers Med | 2024 | https://conductscience.org/library/papers/39338206 | PubMed |
| 39161537 | Can FDG-PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non-small cell lung cancer? | Respirol Case Rep | 2024 | https://conductscience.org/library/papers/39161537 | PubMed |
| 39129250 | 18F-FDG-PET/CT in breast cancer imaging: Restaging and Implications for treatment decisions in a clinical practice setting. | Acta Oncol | 2024 | https://conductscience.org/library/papers/39129250 | PubMed |
| 38989317 | Fluorine-18 FDG PET/CT and New NIMS Grading System for Chemotherapy Response in Breast Cancer. | Indian J Nucl Med | 2024 | https://conductscience.org/library/papers/38989317 | PubMed |
| 38929989 | PET Molecular Imaging in Breast Cancer: Current Applications and Future Perspectives. | J Clin Med | 2024 | https://conductscience.org/library/papers/38929989 | PubMed |
| 38740576 | Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). | Eur J Nucl Med Mol Imaging | 2024 | https://conductscience.org/library/papers/38740576 | PubMed |
| 38304900 | More on treatment de-escalation, biomarkers of response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer: long-term outcomes and translational research findings of the PREDIX HER2 trial. | Ann Transl Med | 2024 | https://conductscience.org/library/papers/38304900 | PubMed |
| 38202160 | Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response. | J Clin Med | 2023 | https://conductscience.org/library/papers/38202160 | PubMed |
| 37958390 | Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958390 | PubMed |
| 37918866 | 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study. | J Nucl Med | 2023 | https://conductscience.org/library/papers/37918866 | PubMed |
| 37746288 | The potential role of combined shear wave elastography and superb microvascular imaging for early prediction the pathological response to neoadjuvant chemotherapy in breast cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/37746288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28477166
GET https://conductscience.org/api/papers/v1/28477166/references?page=2